Citadel Advisors
OFIX icon

Citadel Advisors’s Orthofix Medical OFIX Stock Holding History

Citadel Advisors’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,900
Closed -$160K – 13670
2025
Q3 		$160K Buy
+10,900
New +$143K ﹤0.01% 11489
2025
Q2 		– Sell
-2,200
Closed -$35.9K – 14319
2025
Q1 		$35.9K Buy
2,200
+1,800
+450% +$31.6K ﹤0.01% 12637
2024
Q4 		$6.98K Buy
400
+300
+300% +$5.22K ﹤0.01% 13769
2024
Q3 		$1.56K Sell
100
-3,700
-97% -$59.3K ﹤0.01% 13836
2024
Q2 		$50.4K Sell
3,800
-700
-16% -$9.59K ﹤0.01% 11751
2024
Q1 		$65.3K Buy
+4,500
New +$62.2K ﹤0.01% 11898
2023
Q3 		– Sell
-300
Closed -$5.42K – 14850
2023
Q2 		$5.42K Hold
300
– – ﹤0.01% 13502
2023
Q1 		$5.03K Buy
300
+100
+50% +$1.96K ﹤0.01% 13902
2022
Q4 		$4.11K Buy
+200
New +$3.53K ﹤0.01% 14133
2022
Q1 		– Sell
-6,700
Closed -$208K – 14289
2021
Q4 		$208K Buy
+6,700
New +$224K ﹤0.01% 11769
2019
Q3 		– Sell
-6,000
Closed -$317K – 9592
2019
Q2 		$317K Sell
6,000
-13,600
-69% -$723K ﹤0.01% 7499
2019
Q1 		$1.11M Sell
19,600
-8,100
-29% -$455K ﹤0.01% 5407
2018
Q4 		$1.45M Buy
27,700
+10,700
+63% +$609K ﹤0.01% 4687
2018
Q3 		$983K Sell
17,000
-500
-3% -$28K ﹤0.01% 5577
2018
Q2 		$994K Buy
17,500
+2,400
+16% +$137K ﹤0.01% 5222
2018
Q1 		$888K Buy
15,100
+10,000
+196% +$560K ﹤0.01% 5000
2017
Q4 		$279K Buy
+5,100
New +$264K ﹤0.01% 6579
2015
Q4 		– Sell
-4,000
Closed -$135K – 9043
2015
Q3 		$135K Sell
4,000
-1,500
-27% -$53.4K ﹤0.01% 6637
2015
Q2 		$182K Buy
5,500
+3,700
+206% +$127K ﹤0.01% 6440
2015
Q1 		$65K Sell
1,800
-3,000
-63% -$94.3K ﹤0.01% 7206
2014
Q4 		$144K Buy
4,800
+1,700
+55% +$49.8K ﹤0.01% 6323
2014
Q3 		$96K Buy
+3,100
New +$103K ﹤0.01% 6444

Other funds holding OFIX

ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors's OFIX Position: Q1 2026 in Review

Citadel Advisors increased its Orthofix Medical (OFIX) stake by 547% in Q1 2026, buying an estimated $1.41M and bringing the position to 126,403 shares worth $1.45M. The position accounts for ﹤0.01% of the portfolio, ranked #6791.

Citadel Advisors first reported a position in OFIX in Q2 2013 and has held it in 47 quarters since. The position peaked at $7.35M in Q4 2018. 147 funds tracked by Wall St. Rank hold OFIX as of Q1 2026.

  • Citadel Advisors held 126,403 shares of Orthofix Medical worth $1.45M as of Q1 2026.
  • Citadel Advisors bought 106,858 Orthofix Medical shares in Q1 2026, an estimated $1.41M.
  • Orthofix Medical made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6791 holding.
  • Citadel Advisors first reported a position in Orthofix Medical in Q2 2013 and has held it in 47 quarters since.
  • Citadel Advisors's Orthofix Medical position peaked at $7.35M in Q4 2018.
  • 147 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.